Plain-English translation of NCT07541196 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new wound-healing gel called PAW-hydrogel (a special gel infused with plasma-activated water) to see if it helps chronic wounds heal better than standard care. The study will compare patients who receive the new gel treatment to patients who receive standard advanced wound care. The trial will track how well wounds close over 12 weeks.
Chronic wounds—like diabetic foot ulcers, pressure sores, and leg ulcers—can be very difficult to heal and often last for months or years. Researchers believe this medication may help wounds close faster by promoting healing at the wound site.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will visit the wound clinic 2–3 times per week for up to 12 weeks. At each visit, your wound will be cleaned and either the new gel will be applied (if you're in the treatment group) or standard wound dressing will be applied (if you're in the standard care group). A sterile bandage will cover the area afterward. The study will end when your wound has completely closed or after 12 weeks, whichever comes first.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Mexico